The Drug Enforcement Administration last week launched a new online database for reporting “suspicious orders” of opioids and other controlled substances, such as orders of unusual size, frequency or that deviate substantially from a normal pattern. Hospitals, pharmacies and others who dispense controlled substances must register to report to the database under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. Reporting to SORS Online satisfies the requirement to report such orders to the DEA administrator and special agent in charge of the Division Office of the DEA for the area in which the registrant is located or conducts business. For more information, visit www.deadiversion.usdoj.gov/sors.

Related News Articles

Headline
Addressing social needs, increasing access to medication-assisted treatment and naloxone, as well as better integrating substance use disorder treatment with…
Headline
The Centers for Medicare…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, yesterday concluded a two-day…
Headline
Opioid overdose death rates increased for nearly all racial and ethnic groups in metropolitan areas between 2015 and 2017.
Headline
The Substance Abuse and Mental Health Services Administration today launched FindTreatment.gov, a website to help Americans locate substance use disorder…
Headline
AHA today voiced support for several proposed changes to the federal regulation governing the confidentiality of substance use disorder patients’ records that…